Die Studien und Texte zur Sozialgeschichte der Literatur (STSL) veröffentlichen seit 1975 herausragende literatur-, geschichts- und kulturwissenschaftliche Arbeiten zu vornehmlich deutscher Literatur vom Mittelalter bis zur Gegenwart. Schwerpunkt der literaturgeschichtlichen und theoretischen Abhandlungen sowie der Quellen- und Materialienbände ist das Verhältnis von literarischem Text und gesellschaftlich-historischem Kontext. Als maßgebliche Publikationsreihe einer seit den 1960er Jahren einflussreichen Sozialgeschichte der Literatur prägt STSL zugleich die literaturwissenschaftliche Diskussion über mögliche Austauschbeziehungen zwischen Literatur-, Geschichts- und Sozialwissenschaften.
Although the history of epilepsy, one of the most common serious neurological disorders, can easily be traced back to ancient times, the modern understanding of the disease only began in the middle of the 19th century. This history of the first fifty years of modern epileptology reflects the thinking, accomplishments, and failures of physicians between 1865 and 1914. This epoch presented a very bleak clinical picture: diagnosis was difficult and often arbitrary; treatment was poor and, at times, worse than the disease; and patients, who were usually viewed as having a progressive dementing condition, were shunned by society. Tradition, physicians' immaculate perceptions, their thinking in analogies, and the difficulty a doctor has in separating himself from his society are some of the important factors which led to a lack of clinical advancement during this time. Nevertheless, taking a longer view, a foundation was being established for understanding the physiology of the brain and how that might be related to epilepsy. This book should be of interest to any professional person concerned with or involved in exploring the neurophysiology of brain functions and its deviations, the care and treatment of patience with epilepsy, and the historical and social aspects of medicine.
Wild Forests presents a coherent review of the scientific and policy issues surrounding biological diversity in the context of contemporary public forest management. The authors examine past and current practices of forest management and provide a comprehensive overview of known and suspected threats to diversity. In addition to discussing general ecological principles, the authors evaluate specific approaches to forest management that have been proposed to ameliorate diversity losses. They present one such policy -- the Dominant Use Zoning Model incorporating an integrated network of "Diversity Maintenance Areas" -- and describe their attempts to persuade the U.S. Forest Service to adopt such a policy in Wisconsin. Drawing on experience in the field, in negotiations, and in court, the authors analyze the ways in which federal agencies are coping with the mandates of conservation biology and suggest reforms that could better address these important issues. Throughout, they argue that wild or unengineered conditions are those that are most likely to foster a return to the species richness that we once enjoyed.
This new and timely book looks at the issue that Heritage in general, and in particular urban heritage in Asia, is at the centre of a perfect storm. Populations are increasing rapidly in cities as urbanization grows and there are ever larger numbers of tourists placing significant pressure on urban heritage resources.
From the latest vaccination evidence, recommendations, and protocols . . . to new vaccine development and the use of vaccines in reducing disease, Plotkin’s Vaccines, 8th Edition, covers every aspect of vaccination. Now completely revised and updated from cover to cover, this award-winning text continues to provide reliable information from global authorities, offering a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field. Contains all-new chapters on COVID-19, vaccine hesitancy, and non-specific effects of vaccines, as well as significantly revised content on new vaccine technologies such as mRNA vaccines, emerging vaccines, and technologies to improve immunization. Presents exciting new data on evolution of adjuvants across the centuries, dengue vaccines, human papillomavirus vaccines, respiratory syncytial virus vaccines, tuberculosis vaccines, and zoster vaccines. Provides up-to-date, authoritative information on vaccine production, available preparations, efficacy and safety, and recommendations for vaccine use, with rationales and data on the impact of vaccination programs on morbidity and mortality. Provides complete coverage of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues. Keeps you up to date with information on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. Covers vaccine-preventable diseases, vaccine science, and licensed vaccine products, as well as product technologies and global regulatory and public health issues. Analyzes the cost-benefit and cost-effectiveness of different vaccine options. Helps you clearly visualize concepts and objective data through an abundance of tables and figures.
From the development of each vaccine to its use in reducing disease, Plotkin’s Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin’s Vaccines is a must-have reference for current, authoritative information in this fast-moving field. Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues – plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies. Analyzes the cost-benefit and cost-effectiveness of different vaccine options. Helps you clearly visualize concepts and objective data through an abundance of tables and figures. Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine. Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines. Features a new chapter on maternal immunization.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.